Regencell Bioscience Holdings Ltd RGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $8.19
- Day Range
- $7.87–9.40
- 52-Week Range
- $4.55–68.99
- Bid/Ask
- $8.03 / $8.18
- Shares Outstanding
- 495.88M
- Market Cap
- $4.02B
- Volume/Avg
- 613,068 / 200,787
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 10
Valuation
|
Metric
|
RGC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 304.23 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGC
|
|---|---|
Quick Ratio | 10.77 |
Current Ratio | 10.77 |
Interest Coverage | — |
Quick Ratio
RGC
Profitability
|
Metric
|
RGC
|
|---|---|
Return on Assets (Normalized) | −108.22% |
Return on Equity (Normalized) | −130.88% |
Return on Invested Capital (Normalized) | −125.46% |
Return on Assets
RGC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|g!&nd?& | LOCK|BxRb% | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|>@Q?FTkv | LOCK|f^xdS | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|T#SQ&gF | LOCK|HTY | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|Nr!V$<V | LOCK|FQv | $31B | |||
| Viatris Inc
VTRS
| LOCK|NH&%J< | LOCK|dc$ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|%v | LOCK|gw< | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|p^<rT!< | LOCK|%? | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&M?<#@? | LOCK|j$ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|PdZsc!> | LOCK|KW&<t | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|v<^zcCL | LOCK|?^# | $2B |
United States